Pharmaceutical company Merck is partnering with biotechnology company Orna Therapeutics to develop treatments in oncology and infectious diseases; Merck will pay $150 million upfront to Orna.
Pharmacy
A tuberculosis vaccine that's 100 years old and costs less than a dollar per dose could have a shot at preventing COVID-19 infections, according to researchers from Boston's Massachusetts General Hospital.
Paxlovid, Pfizer's popular antiviral drug treatment, is leaving a sour taste in people's mouths, The Wall Street Journal reported Aug. 16.
After Roe v. Wade was overturned in June, access to some drugs and pharmacy products related to pregnancy, such as condoms, has been strained, and some pharmacies are scrambling to provide healthcare without breaking laws.
Truepill has reduced its global workforce by 14 percent in another round of job cuts for the digital pharmacy, a spokesperson told Becker's.
Advertisement
Rite Aid will team up with WellSpan Health, an eight-hospital system with locations scattered across Pennsylvania and Maryland, to weave the two organizations' priorities together and improve health outcomes of patients.
Pfizer Chairman and CEO Albert Bourla, PhD, has tested positive for COVID-19, the executive said in an Aug. 15 statement on the company's website.
Cambridge, Mass.-based healthcare investment fund Gurnet Point Capital and Menlo Park Calif.-based healthcare investment firm Patient Square Capital completed their acquisition of biopharmaceutical company Radius Health, the company said Aug. 15.
Save Mart, a grocery store chain concentrated in California and Nevada, plans to shutter its 89 pharmacies and move its services to Walgreens Aug. 16, according to the Reno Gazette Journal and the Union Democrat.
Health experts are questioning the length of Pfizer's antiviral treatment, as COVID-19 rebounds seem to exceed "rare" status, according to Time.